Functional intracellular renin-angiotensin systems: Potential for pathophysiology of disease

American Journal of Physiology - Regulatory Integrative and Comparative Physiology

Volumn 302, Issue 5, 2012, Pages

  Carey, Robert M ^a  

^a UNIVERSITY OF VIRGINIA HEALTH SYSTEM   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOTENSIN; ANGIOTENSIN 2 RECEPTOR;

CELL NUCLEUS; DIABETES MELLITUS; EDITORIAL; HORMONE TRANSPORT; HYPERTENSION; KIDNEY PROXIMAL TUBULE; KIDNEY TUBULE ABSORPTION; MITOCHONDRION; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; TRANSGENIC MOUSE;

CARDIOVASCULAR DISEASES; HEART; HOMEOSTASIS; HUMANS; KIDNEY; KIDNEY DISEASES; MYOCARDIUM; RENIN-ANGIOTENSIN SYSTEM;

EID: 84857820252     PISSN: 03636119     EISSN: 15221490     Source Type: Journal    
DOI: 10.1152/ajpregu.00656.2011     Document Type: Editorial

References (25)

1. Abadir PM, Foster DB, Crow M, Cooke CA, Rucker JJ, Jain A, Smith, BJ, Burks TN, Cohn RD, Fedarko NS, Carey RM, O'Rourke B, Walston JD. Identification and characterization of a functional mito-chondrial angiotensin system. Proc Nat Acad Sci USA 108: 14849-14854, 2011.
2. Akazawa H, Yasuda N, Komuro I. Mechanisms and functions of agonist-independent activation in the angiotensin II type 1 receptor. Mol Cell Endocrinol 302: 140-147, 2009.
3. Benigni A, Corna D, Zoja C, Sonzogni A, Latini R, Salio M, Conti S, Rottoli D, Longaretti L, Cassis P, Morigi M, Coffman TM, Remuzzi G. Disruption of the Ang II type 1 receptor promotes longevity in mice. J Clin Invest 119: 524-530, 2009.
4. Carey RM, Siragy HM. Newly recognized components of the renin-angiotensin system: potential roles in cardiovascular and renal regulation. Endocrinol Rev 24: 261-271, 2005.
5. Cassis P, Conti S, Remuzzi G, Benigni A. Angiotensin receptors as determinants of the life span. Pflügers Arch 459: 325-332, 2010.
6. Cheng H, Fan X, Moeckel GW, Harris RC. Podocyte COX-2 exacerbates diabetic nephropathy by increasing podocyte (pro)renin receptor expression. J Am Soc Nephrol 22: 1240-1251, 2011.
7. Cook JL, Re RN. Lessons from in vitro studies and a related intracellular angiotensin KK transgenic mouse model. Am J Physiol Regul Integr Comp Physiol (December 14, 2011). doi:10.1152/ajpregu.00493.2011.
8. Davisson RL, Ding Y, Stec DE, Caterall JF, Sigmund CD. Novel mechanism of hypertension revealed by cell-specific targeting of human angiotensinogen in transgenic mice. Physiol Genomics 15: 3-9, 1999.
9. De Mello WC, Frohlich ED. On the local cardiac renin angiotensin system: basic and clinical implications. Peptides 32: 1774-1779, 2011.
10. Ellis B, Li XC, Miguel-Qin E, Gu V, Zhuo JL. Evidence for a functional intracellular angiotensin system in the proximal tubule of the kidney. Am J Physiol Regul Integr Comp Physiol (December 14, 2011). doi:10.1152/ ajpregu.00487.2011.
11. Grobe JL, Grobe CL, Beltz TG, Westphal SG, Morgan DA, Xu D, deLange WJ, Li H, Sakai K, Thedens DR, Cassis LA, Rahmouni K, Mark AL, Johnson AK, Sigmund CD. The brain renin-angiotensin system controls divergent efferent mechanisms to regulate fluid and energy balance. Cell Metab 12: 431-442, 2010.
12. Grobe JL, Xu D, Sigmund CD. An intracellular renin-angiotensin system in neurons: fact, hypothesis, or fantasy? Physiology 23: 187-193, 2008.
13. Gwathmey TM, Alzayadneh EM, Pendergrass KD, Chappell MC. Novel roles of nuclear angiotensin receptors and signaling mechanisms. Am J Physiol Regul Integr Comp Physiol (December 14, 2011). doi: 10.1152/ajpregu.00525.2011.
14. Huang J, Siragy HM. Regulation of (pro)renin receptor expression by glucose-induced mitogen-activated protein kinase, nuclear factor-kB and activator protein-1 signaling pathways. Endocrinology 151: 3317-3325, 2010.
15. Kimbrough HM, Vaughan ED, Carey RM, Ayers CR. Effect of intrarenal angiotensin II on renal function in conscious dogs. Circ Res 40: 174-178, 1977.
16. Kumar R, Yong QC, Thomas CM, Baker KM. Intracardiac intracellular angiotensin system in diabetes. Am J Physiol Regul Integr Comp Physiol (December 14, 2011). doi:10.1152/ajpregu.00512.2011.
17. Levens NR, Freedlender AE, Peach MJ, Carey RM. Control of renal function by intrarenal angiotensin II. Endocrinology 112: 43-49, 1983.
18. Levens NR, Peach MJ, Carey RM. Role of the intrarenal renin-angiotensin system in the control of renal function. Circ Res 48: 157-167, 1981.
19. Miura S, Fujino M, Hanzawa H, Kiya Y, Imaizumi S, Matsuo Y, Tomita S, Uehara Y, Karnik SS, Yanigazawa H, Koike H, Komuro I, Saku K. Molecular mechanism underlying inverse agonist of angiotensin II type 1 receptor. J Biol Chem 28: 19288-19295, 2006.
20. Navar LG, Kobori H, Prieto MC, Gonzalez-Villalobos RA. Intratubular renin-angiotensin system in hypertension. Hypertension 57: 355-362, 2011.
21. Re RN. Tissue renin-angiotensin systems. Med Clin North Am 88: 19-38, 2004.
22. Re RN, Cook JL. Noncanonical intracrine action. J Am Soc Hypertens 5: 435-448, 2011.
23. Re RN, McPhee AA, Fallon JT. Specific nuclear binding of angiotensin II by rat liver and spleen nuclei. Clin Sci (Lond) 61 Suppl 7: 245s-247s, 1981.
24. Sakai K, Sigmund CD. Molecular evidence of tissue renin-angiotensin systems: focus on the brain. Curr Hypertens Rep 7: 135-140, 2005.
25. Wright JW, Harding JW. Brain renin-angiotensin-a new look at an old system. Prog Neurol 95: 49-67, 2011.